Related Experiment Video
Updated: May 27, 2026
Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
Value of muscle enzyme measurement in evaluating different neuromuscular diseases
Yue Zhang1, Jing-Jing Huang, Zhi-Qiang Wang
1Department of Neurology and Institute of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
Background:
Muscle enzymes sometimes can provide clues for many similar neuromuscular disorders. However literatures that described and compared the muscle enzyme levels among these diseases are few. We described their changes in a group of Chinese patients.
Methods:
We reviewed creatine kinase (CK), lactate dehydrogenase (LDH), aspartate transaminase (AST) levels and CK/lDH in Chinese patients with Duchene/Becker muscular dystrophy (DMD/BMD), facioscapulohumeral muscular dystrophy (FSHD), limb-girdle muscular dystrophy (LGMD), polymyositis (PM), lipid storage myopathy (LSM), motor neuron disease (MND) and spinal muscular atrophy (SMA). The diagnosis of DMD/BMD, FSHD, LSM and SMA was confirmed by genetic analysis. Comparisons between groups were tested by One-Way ANOVA analysis and LSD test.
Results:
CK: DMD/BMD>PM>LGMD>LSM>FSHD>MND>SMA. LDH and AST: DMD/BMD>LSM>PM>LGMD>FSHD>SMA>MND. For MND, logCK in PMA is the highest. For SMA, logCK value in type III is the highest. LDH disproportionately elevates in LSM and SMA.
Conclusion:
This investigation described muscle enzyme profiles in a large cohort of Chinese patients with neuromuscular diseases. Muscle enzyme values may have some implications for making decision when the diagnosis is hard.
